Elicio Therapeutics, Inc.
ELTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$51,898 | -$35,195 | -$28,208 | -$26,401 |
| Dep. & Amort. | $1,178 | $1,170 | $1,057 | $251 |
| Deferred Tax | $0 | $0 | $0 | $53 |
| Stock-Based Comp. | $1,452 | $1,179 | $579 | $618 |
| Change in WC | $3,959 | -$57 | -$150 | $872 |
| Other Non-Cash | $8,241 | $209 | $4,543 | $667 |
| Operating Cash Flow | -$37,068 | -$32,694 | -$22,179 | -$23,939 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$87 | -$66 | -$654 | -$525 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $3 | $34 | $0 | $0 |
| Investing Cash Flow | -$84 | -$32 | -$654 | -$525 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $19,727 | $10,000 | $0 | $14,032 |
| Stock Issued | $5,635 | $6,999 | $0 | $101 |
| Stock Repurch. | $0 | -$150 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $16,959 | $21,764 | $21,202 | $5,260 |
| Financing Cash Flow | $42,321 | $38,613 | $21,202 | $19,394 |
| Forex Effect | $22 | $0 | $0 | $0 |
| Net Chg. in Cash | $5,191 | $5,887 | -$1,631 | -$5,071 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,301 | $8,414 | $10,045 | $15,115 |
| End Cash | $19,492 | $14,301 | $8,414 | $10,045 |
| Free Cash Flow | -$37,155 | -$32,760 | -$22,833 | -$24,464 |